Season 8 · Episode 19
S8 Ep19: FDA Approval Insights: Tucatinib and Trastuzumab in HER2+ mCRC
OncLive® On Air · OncLive® On Air
February 6, 20239m 36s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr Strickler discusses the FDA approval of tucatinib plus trastuzumab in metastatic colorectal cancer, key efficacy and safety findings from the MOUNTAINEER trial, and ongoing research seeking to address remaining unmet needs in this population.